Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/8AP stock hub

FRA/8AP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/8APis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.4B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/8APFRA/8AP

—

Loading chart…

In the news

Latest news · FRA/8AP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-32.8

P25 n/aP50 n/aP75 n/a

ROIC-120.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/8AP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

160

Groups with data

Currency

USD

Showing 160 of 160 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	540
Employees Change	52%
Employees Change Percent	10.66
Enterprise value	EUR 546.3M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 1.4B
Price	EUR 23.2
Price currency	EUR
Rev Per Employee	106,080.43x
Sic	2836
Symbol	fra/8AP
Website	https://www.agios.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-26.1%
EV Earnings	-1.49x
EV/FCF	-1.64x
EV/Sales	9.73x
FCF yield	-23.76%
P/B ratio	1.46x
P/S ratio	24.51x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -250.2M
Net Income	EUR -366.5M
Pretax Margin	-641.38%
Profit Per Employee	EUR -678,747
ROA	-21.69
Roa5y	-20.34
ROCE	-42.23
ROE	-32.82
Roe5y	-14.25
ROIC	-120.9
Roic5y	-138.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-4.58%
Cagr1y	-6.46%
Cagr3y	1.79%
Cagr5y	-12.83%
Revenue Growth	78.34x
Revenue Growth Q	137.75x
Revenue Growth3 Y	51.44x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.05
Assets	EUR 1B
Cash	EUR 639.2M
Current Assets	EUR 707.9M
Current Liabilities	EUR 49.9M
Debt	EUR 31M
Debt Equity	EUR 0.03
Debt FCF	EUR -0.09
Equity	EUR 961.9M
Liabilities	EUR 65.8M
Long Term Assets	EUR 319.8M
Long Term Liabilities	EUR 15.9M
Net Cash	EUR 875.8M
Net Cash By Market Cap	EUR 62.37
Net Cash Growth	-26.39%
Net Debt Equity	EUR -0.91
Tangible Book Value	EUR 961.9M
Tangible Book Value Per Share	EUR 16.21

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.19
Inventory Turnover	10.96
Net Working Capital	EUR 50.1M
Quick ratio	12.8
Working Capital	EUR 673M
Working Capital Turnover	EUR 0.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.25%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-37.4%
1Y total return	-6.45%
200-day SMA	27.98
3Y total return	5.46%
50-day SMA	25
50-day SMA vs 200-day SMA	50under200
5Y total return	-49.65%
All Time High	116.1
All Time High Change	-80.02%
All Time High Date	2015-01-19
All Time Low	11.62
All Time Low Change	99.6%
All Time Low Date	2013-11-26
ATR	0.76
Ch YTD	0.87
High	23.2
High52	38.8
High52 Date	2025-11-19
High52ch	-40.21%
Low	23.2
Low52	19.7
Low52 Date	2025-11-20
Low52ch	17.77%
Ma50ch	-7.19%
Price vs 200-day SMA	-17.07%
RSI	44.52
RSI Monthly	42.92
RSI Weekly	44.25
Sharpe ratio	0.27x
Sortino ratio	0.39
Total Return	-0.25%
Tr YTD	0.87
Tr1m	-21.62%
Tr1w	-2.52%
Tr3m	3.57%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -412.4M
Operating margin	-720

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	50,618,619%
Shares Insiders	1.11%
Shares Institutions	95.25%
Shares Qo Q	0.74%
Shares Yo Y	0.25%
Short Ratio	6.7

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -382.9M
Average Volume	9x
Bv Per Share	16.21
CAPEX	EUR -3.7M
Ch10y	-37.4
Ch1m	-21.62
Ch1w	-2.52
Ch1y	-6.45
Ch3m	3.57
Ch3y	5.46
Ch5y	-49.65
Ch6m	-33.33
Change	1.75%
Change From Open	0
Close	22.8
Days Gap	1.75
Depreciation Amortization	4,461,976
Earnings Date	2026-04-29
EBIT	EUR -412.4M
EBITDA	EUR -407.9M
EPS	EUR -6.29
F Score	3
FCF	EUR -333.7M
FCF EV Yield	-61.08x
Financing CF	7,922,786
Fiscal Year End	December
Founded	2,007
Income Tax	EUR -881,177
Investing CF	352,044,876
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Ma150	26.71
Ma150ch	-13.13%
Ma20	24.55
Ma20ch	-5.5%
Net CF	30,039,803
Open	23.2
Ppne	32,020,741
Price Date	2026-05-08
Ptbv Ratio	1.46
Relative Volume	20x
Revenue	57,283,430x
SBC By Revenue	85.9x
Share Based Comp	49,205,398
Tax By Revenue	-1.54x
Tr6m	-33.33%
Volume	0
Z Score	13.86

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/8AP pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/8AP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/8AP?

Insider, institutional, and short-interest positioning.

Institutional ownership

+95.3%

Share of float held by funds and institutions

Insider ownership

+1.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/8AP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.5

Neutral momentum band

Price vs 200-day MA

-17.1%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.27

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/8AP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/8AP stock rating?

fra/8AP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/8AP analysis?

The full report lives at /stocks/fra/8AP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/8AP?

The latest report frames fra/8AP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/8AP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.